Home › Multiple Myeloma › California › San Francisco

Pag-aaral pangklinika para sa Multiple Myeloma sa San Francisco, CA

Isang pag-aaral para sa Multiple Myeloma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa San Francisco. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Nagre-recruitPhase 1

University of California San Francisco, San Francisco

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05652335

A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events

Nagre-recruitPhase 2

University of California San Francisco, San Francisco

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06500884

A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

Nagre-recruitPhase 2

University of California San Francisco, San Francisco

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07149857

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

Nagre-recruitPhase 3

University of California San Francisco, San Francisco

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07258511

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Nagre-recruitPhase 4

University of California San Francisco, San Francisco

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05201781

A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

Nagre-recruitPhase 1/2

UCSF, San Francisco

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07116616

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Nagre-recruitPhase 2

Kaiser Permanente - South San Francisco Medical Center, San Francisco
California Pacific Medical Center Research Institute, San Francisco
Kaiser Permanente - San Francisco Medical Center, San Francisco
at 1 pa

Edad 12 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT02693535

Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

Nagre-recruitPhase 1

University of California, San Francisco, San Francisco

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT05892393

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

Nagre-recruitPhase 2

UCSF Helen Diller Medical Center at Parnassus Heights, San Francisco

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06297226

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

Nagre-recruitPhase 1

UCSF, San Francisco

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07075185

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

Nagre-recruitPhase 1

UCSF Medical Center - Hematology and Blood and Marrow Transplant Clinic, San Francisco

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT05651932

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

Nagre-recruitPhase 1/2

Research Site, San Francisco

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05850234

Delayed Toxicities Post-CAR-T

Nagre-recruitObservasyonal na pag-aaral

UCSF Medical Center, San Francisco

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07665307

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

Nagre-recruitPhase 1

UCSF Helen Diller Medical Center at Parnassus Heights, San Francisco

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 18, 2026 · NCT06153251

Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma

Nagre-recruitPhase 1

University of Calfornia, San Francisco, San Francisco

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT06348108

Pag-aaral para sa Multiple Myeloma sa ibang lungsod

Iba pang pag-aaral sa San Francisco

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.